New anti–vascular endothelial growth factor (VEGF) therapies are improving retinal disease management by providing patients ...

D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and ...

Physicians’ Education Resource (PER) has launched Retina Resource, a comprehensive source of education and information on the ...

Physicians’ Education Resource (PER ®) is excited to announce the launch of Retina Resource, a comprehensive source of cutting-edge education and information on the latest innovations in anti-VEGF ...

Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal ...

Obstructive sleep apnea is associated with higher rates of age-related macular degeneration development and progression.

Striking study results last year indicated a new type of medicine may improve on Merck’s immunotherapy, spurring a wave of ...